Want to join the conversation?
$MRK 2Q15 Call: Last month, the FDA accepted the supplemental BLA for KEYTRUDA, an advanced non-small cell lung cancer, and granted KEYTRUDA Priority Review. This past week, the European Commission approved KEYTRUDA for the treatment of advanced melanoma in adults, both as a first line therapy and in previously treated patients.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.
$RAI has received a $47 billion take over offer from British tobacco giant British American Tobacco! This is huge!